Contact Us

Have questions? 

Please email us at casl@hepatology.ca or call us at 780-436-0983 ext.234

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

Presentations

To access the pdf version of the presentation, please click on the session title


Friday - 8th Canadian Symposium on Hepatitis C

Click on the presentation title to view the pdf version of the slides: 

Session #1: Biomedical Research

Session #2: Social, Cultural, Environmental and Population Health Research

  • Diagnostic Testing for Hepatitis C Infection: Where Are We Now and What Does the Future Hold - Stuart C. Ray, Johns Hopkins University School of Medicine

  • Hepatitis C and HIV Testing from Dried Blood Spots: Simplifying Testing to Broaden Community Based Testing - John Kim, Public Health Agency of Canada NO PRESENTATION

  • Estimation of an Individual-Level Deprivation Index for HIV/HCV Co-Infected Persons - Adam Palayew, McGill University

  • Opioid Agonist Treatment and Risk of Hepatitis C Virus Infection Among People Who Inject Drugs: The Overlooked Role of Dosage Adequacy - Andreea Adelina Artenie, Université de Montréal

Session #3: Clinical Research

Session #4: Health Services Research

Blueprint to Inform Hepatitis C Elimination Efforts in Canada

  • Dr. Jordan Feld, Melisa Dickie, Lindsay Jennings, Julie Bruneau, Mel Krajden, Marina Klei


Saturday - Canadian Liver Meeting

Click on the presentation title to view the pdf version of the slides: 

Breakfast Symposia

HCC Basic/Translational


Public Health


Viral Hepatitis Oral Abstract Presentations

CAHN Session

New Clinical Developments

Mechanisms of Liver Injury and Repair in NAFLD and Viral Hepatitis


Public Health and Best Practice Clinical Management


Evolving Evidence in Liver Disease Pathogenesis and Best Clinical Management

CAHN Session - HCV Models of Care Among Priority Populations: Nursing Practice and Pearls

CASL-CLF Sass-Kortsak Lecture - Fernando Alvarez, CHU-Sainte Justine


Pediatric Symposium


Sunday - Canadian Liver Meeting

Click on the presentation title to view the pdf version of the slides: 

General Hepatology Oral Abstract Presentations

  • Vitamin E is an Effective Treatment for NASH in People Living with HIV: The CTN-PT 024 Trial - Giada Sebastiani, McGill University

  • Why Women Develop Less Hepatocellular Carinoma: The Centrality of ESR1 and the Estrogen Effect - Mamatha Bhat, Multi Organ Transplant Program, UHN NO PRESENTATION

  • CD8+ T-cell Dysfunction in a Murine Model of Liver Fibrosis - Angela M. Crawley, University of Ottawa

  • Implementation of a Primary Care Shear-Wave Elastography (SWE) Based Pathway to NAFLD Patients with Advanced Fibrosis in a Large North American Urban Population - Abdel Aziz Shaheen, University of Calgary

  • Acyl CoA Thioesterase 1 Promotes Transition from Steatosis to Non-Alcoholic Steatohepatitis - Elisa Pasini, UHN

End Stage Liver Disease and Liver Transplantation

  • Referral and Optimizing Pre-Transplant in NASH/NAFLD - Giada Sebastini, McGill University

  • Use of HCV + Organ in Transplant Patients - Jordan Feld, University Health Network

  • Sex and Gender Differences in Listing and Allocation for Liver Transplant - Mamatha Bhat, University of Toronto NO PRESENTATION

Immune Control/Dysfunction and Liver Disease


Gold Medal Lecture

Updates on the Treatments of Ascites and Hepatorenal Syndrome - Florence Wong, University Health Network Toronto